13 hours BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq Fast Company
BioAge Labs is having its initial public offering today. The drug developer’s signature product, Azelaprag, isn’t yet on sale, but it is undergoing clinical trials in hopes it will one day be.
What does Azelaprag do? It’s a weight loss drug that, …